These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 32007441)

  • 1. Long-term effects of continuous subcutaneous insulin infusion in adults with type 1 diabetes mellitus patients: Results of a public healthcare system.
    Moreno-Fernandez J; López LM; Gomez FJ; Pinés P; Blanco B; González J; López J; Herranz S; Roa C; Gómez-Romero FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Feb; 68(2):116-122. PubMed ID: 32007441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
    Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
    Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain.
    Beato-Víbora P; Chico-Ballesteros A; Giménez M; Guerrero-Vázquez R; Barrio-Castellanos R; Goñi-Iriarte MJ; Díaz-Soto G; Merino-Torres JF; Moreno-Fernández J; Martínez-Brocca MA;
    Diabetes Res Clin Pract; 2018 Mar; 137():56-63. PubMed ID: 29278712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up.
    Coronel-Restrepo N; Blanco VM; Palacio A; Ramírez-Rincón A; Arbeláez S; Duque V; Pino JJ; Carvajal J; Bedoya J; Cuesta DP; Botero JF
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Oct; 68(8):567-572. PubMed ID: 34872640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.
    ; Mousa M; Al-Mahdi M; Al-Sanaa H; ; Al-Kandari H
    Oman Med J; 2015 Sep; 30(5):336-43. PubMed ID: 26421114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
    Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
    Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up.
    Coronel-Restrepo N; Blanco VM; Palacio A; Ramírez-Rincón A; Arbeláez S; Duque V; Pino JJ; Carvajal J; Bedoya J; Cuesta DP; Botero JF
    Endocrinol Diabetes Nutr (Engl Ed); 2020 Dec; ():. PubMed ID: 33358488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
    Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control.
    Quirós C; Giménez M; Ríos P; Careaga M; Roca D; Vidal M; Conget I
    Diabet Med; 2016 Oct; 33(10):1422-6. PubMed ID: 26870914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
    Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
    Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
    [No Abstract]   [Full Text] [Related]  

  • 17. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pumps use in Greece: Efficacy and safety data from 140 patients with type 1 diabetes mellitus.
    Somali M; Paschou SA; Mouslech Z
    Diabetes Res Clin Pract; 2020 Feb; 160():108026. PubMed ID: 31954749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.